Buffett described how share prices do not reflect business value, discussing the role of TSR and dividends in the context of Royalty Pharma.

2 reports, 0 independent Updated Jun 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Buffett described how share prices do not reflect business value, discussing the role of TSR and dividends in the context of Royalty Pharma.

Who's involved

What this event is mainly about

Warren Buffett Royalty Pharma TSR

Keep exploring

Part of

Warren Buffett discussed the difference between share price and business value, alongside the role of TSR in total shareholder return. All 2 developments

The entities involved

Warren Buffett
American investor, entrepreneur and businessman
- Berkshire Hathaway, led by Warren Buffett, holds stakes in American Express and Moody's Corporation, demonstrating its diverse investment strategy.Mon 00:05
- Berkshire Hathaway made a major corporate move by acquiring a large stake in Alphabet (Google).Sun 14:53
Royalty Pharma
biopharmaceutical company based in New York City
- Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.Sun 17:49
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sun 02:34
TSR
former company, publisher of Dungeons & Dragons

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jun 29Unknown outlet
Jun 22Unknown outlet